Rani Nair, MD
Internal Medicine · Springfield, MONPI 1538366448
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,700 of the $13,385 with a category attached, or 94.9%. Amgen accounts for 97.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $6,802 and has fallen 90.3% since, to $660 in 2025. Among internal medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $243.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$13K
- Dexcom, Inc.$132
- Medtronic$105
- Intuitive Surgical$44
- Sequel Med Tech, LLC$29
- Abbott$19
- plus $20 from 2 others
What the payments were for
- Speaking & faculty fees$12,70095%
- Food & beverage$6805%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 27 | $13,037 |
| Dexcom, Inc. | 21 | $132 |
| Medtronic | 1 | $105 |
| Intuitive Surgical | 1 | $44 |
| Sequel Med Tech, LLC | 2 | $29 |
| Abbott | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$9,600
- Prolia$3,100
- Minimed 670G System$105
How this compares
$13,385 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 267 | $421,903 |
| JardianceEmpagliflozin | 181 | $184,891 |
| MounjaroTirzepatide | 87 | $135,909 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 38 | $76,163 |
| Tresiba Flextouch U-200Insulin Degludec | 56 | $66,377 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 281 | $56,125 |
| Tresiba Flextouch U-100Insulin Degludec | 58 | $45,604 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $39,354 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $35,224 |
| RybelsusSemaglutide | 27 | $34,362 |
| TrulicityDulaglutide | 15 | $33,603 |
| Novolog FlexpenInsulin Aspart | 122 | $32,510 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 54 | $32,480 |
| JanuviaSitagliptin Phosphate | 31 | $26,907 |
| Humalog Kwikpen U-100Insulin Lispro | 46 | $24,774 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Springfield
- Melissa GainesSpringfield$16K
- Stephen HolmesSpringfield$13K
- Timothy SmithSaint Peters$428K
- Craig DietzKansas City$226K
- Kevin SuttmoellerKansas City$198K
- Vinay KamatSaint Louis$191K
- David PrelutskySaint Louis$182K
- Dima DandachiColumbia$157K
- Justin SteinkampSaint Charles$139K
- Tracy NorfleetSaint Louis$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.